AI assistant
Sending…
Athira Pharma, Inc. — Director's Dealing 2024
Apr 16, 2024
35038_dirs_2024-04-16_b8582386-8938-44ce-92e9-62379909fe44.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2024-04-15
Reporting Person: San Martin Javier (N/A)
More from Athira Pharma, Inc.
Annual Report
2026
May 11
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 31
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Feb 23
Major Shareholding Notification
2026
Feb 6
Regulatory Filings
2026
Jan 20
Regulatory Filings
2026
Jan 20